1 Study Coverage
    1.1 Super Generic Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Super Generic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Traditional Generic Drugs
        1.2.3 Biosimilars
    1.3 Market by Application
        1.3.1 Global Super Generic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 CNS
        1.3.3 Cardiovascular
        1.3.4 Genitourinary/Hormonal Drugs
        1.3.5 Respiratory
        1.3.6 Rheumatology
        1.3.7 Diabetes
        1.3.8 Oncology
        1.3.9 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Super Generic Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Super Generic Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Super Generic Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Super Generic Drugs Sales by Region
        2.4.1 Global Super Generic Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Super Generic Drugs by Region (2023-2028)
    2.5 Global Super Generic Drugs Revenue by Region
        2.5.1 Global Super Generic Drugs Revenue by Region (2017-2022)
        2.5.2 Global Super Generic Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Super Generic Drugs Sales by Manufacturers
        3.1.1 Global Top Super Generic Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Super Generic Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Super Generic Drugs in 2021
    3.2 Global Super Generic Drugs Revenue by Manufacturers
        3.2.1 Global Super Generic Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Super Generic Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Super Generic Drugs Revenue in 2021
    3.3 Global Super Generic Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Super Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Super Generic Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Super Generic Drugs Sales by Type
        4.1.1 Global Super Generic Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Super Generic Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Super Generic Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Super Generic Drugs Revenue by Type
        4.2.1 Global Super Generic Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Super Generic Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Super Generic Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Super Generic Drugs Price by Type
        4.3.1 Global Super Generic Drugs Price by Type (2017-2022)
        4.3.2 Global Super Generic Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Super Generic Drugs Sales by Application
        5.1.1 Global Super Generic Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Super Generic Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Super Generic Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Super Generic Drugs Revenue by Application
        5.2.1 Global Super Generic Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Super Generic Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Super Generic Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Super Generic Drugs Price by Application
        5.3.1 Global Super Generic Drugs Price by Application (2017-2022)
        5.3.2 Global Super Generic Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Super Generic Drugs Market Size by Type
        6.1.1 North America Super Generic Drugs Sales by Type (2017-2028)
        6.1.2 North America Super Generic Drugs Revenue by Type (2017-2028)
    6.2 North America Super Generic Drugs Market Size by Application
        6.2.1 North America Super Generic Drugs Sales by Application (2017-2028)
        6.2.2 North America Super Generic Drugs Revenue by Application (2017-2028)
    6.3 North America Super Generic Drugs Market Size by Country
        6.3.1 North America Super Generic Drugs Sales by Country (2017-2028)
        6.3.2 North America Super Generic Drugs Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Super Generic Drugs Market Size by Type
        7.1.1 Europe Super Generic Drugs Sales by Type (2017-2028)
        7.1.2 Europe Super Generic Drugs Revenue by Type (2017-2028)
    7.2 Europe Super Generic Drugs Market Size by Application
        7.2.1 Europe Super Generic Drugs Sales by Application (2017-2028)
        7.2.2 Europe Super Generic Drugs Revenue by Application (2017-2028)
    7.3 Europe Super Generic Drugs Market Size by Country
        7.3.1 Europe Super Generic Drugs Sales by Country (2017-2028)
        7.3.2 Europe Super Generic Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Super Generic Drugs Market Size by Type
        8.1.1 Asia Pacific Super Generic Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Super Generic Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Super Generic Drugs Market Size by Application
        8.2.1 Asia Pacific Super Generic Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Super Generic Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Super Generic Drugs Market Size by Region
        8.3.1 Asia Pacific Super Generic Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Super Generic Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Super Generic Drugs Market Size by Type
        9.1.1 Latin America Super Generic Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Super Generic Drugs Revenue by Type (2017-2028)
    9.2 Latin America Super Generic Drugs Market Size by Application
        9.2.1 Latin America Super Generic Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Super Generic Drugs Revenue by Application (2017-2028)
    9.3 Latin America Super Generic Drugs Market Size by Country
        9.3.1 Latin America Super Generic Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Super Generic Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Super Generic Drugs Market Size by Type
        10.1.1 Middle East and Africa Super Generic Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Super Generic Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Super Generic Drugs Market Size by Application
        10.2.1 Middle East and Africa Super Generic Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Super Generic Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Super Generic Drugs Market Size by Country
        10.3.1 Middle East and Africa Super Generic Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Super Generic Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Teva
        11.1.1 Teva Corporation Information
        11.1.2 Teva Overview
        11.1.3 Teva Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Teva Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Teva Recent Developments
    11.2 Novartis - Sandoz
        11.2.1 Novartis - Sandoz Corporation Information
        11.2.2 Novartis - Sandoz Overview
        11.2.3 Novartis - Sandoz Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Novartis - Sandoz Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Novartis - Sandoz Recent Developments
    11.3 Mylan
        11.3.1 Mylan Corporation Information
        11.3.2 Mylan Overview
        11.3.3 Mylan Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Mylan Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Mylan Recent Developments
    11.4 Sun Pharmaceutical
        11.4.1 Sun Pharmaceutical Corporation Information
        11.4.2 Sun Pharmaceutical Overview
        11.4.3 Sun Pharmaceutical Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Sun Pharmaceutical Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Sun Pharmaceutical Recent Developments
    11.5 Aspen
        11.5.1 Aspen Corporation Information
        11.5.2 Aspen Overview
        11.5.3 Aspen Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Aspen Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Aspen Recent Developments
    11.6 Fresenius Kabi
        11.6.1 Fresenius Kabi Corporation Information
        11.6.2 Fresenius Kabi Overview
        11.6.3 Fresenius Kabi Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Fresenius Kabi Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Fresenius Kabi Recent Developments
    11.7 Pfizer (Hospira)
        11.7.1 Pfizer (Hospira) Corporation Information
        11.7.2 Pfizer (Hospira) Overview
        11.7.3 Pfizer (Hospira) Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Pfizer (Hospira) Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Pfizer (Hospira) Recent Developments
    11.8 Sanofi
        11.8.1 Sanofi Corporation Information
        11.8.2 Sanofi Overview
        11.8.3 Sanofi Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Sanofi Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Sanofi Recent Developments
    11.9 Aurobindo
        11.9.1 Aurobindo Corporation Information
        11.9.2 Aurobindo Overview
        11.9.3 Aurobindo Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Aurobindo Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Aurobindo Recent Developments
    11.10 Lupin
        11.10.1 Lupin Corporation Information
        11.10.2 Lupin Overview
        11.10.3 Lupin Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Lupin Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Lupin Recent Developments
    11.11 Dr. Reddy's
        11.11.1 Dr. Reddy's Corporation Information
        11.11.2 Dr. Reddy's Overview
        11.11.3 Dr. Reddy's Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Dr. Reddy's Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Dr. Reddy's Recent Developments
    11.12 Apotex
        11.12.1 Apotex Corporation Information
        11.12.2 Apotex Overview
        11.12.3 Apotex Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Apotex Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Apotex Recent Developments
    11.13 Cipla
        11.13.1 Cipla Corporation Information
        11.13.2 Cipla Overview
        11.13.3 Cipla Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Cipla Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Cipla Recent Developments
    11.14 ENDO (Par Pharmaceutical)
        11.14.1 ENDO (Par Pharmaceutical) Corporation Information
        11.14.2 ENDO (Par Pharmaceutical) Overview
        11.14.3 ENDO (Par Pharmaceutical) Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 ENDO (Par Pharmaceutical) Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 ENDO (Par Pharmaceutical) Recent Developments
    11.15 Stada Arzneimittel
        11.15.1 Stada Arzneimittel Corporation Information
        11.15.2 Stada Arzneimittel Overview
        11.15.3 Stada Arzneimittel Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Stada Arzneimittel Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Stada Arzneimittel Recent Developments
    11.16 Krka Group
        11.16.1 Krka Group Corporation Information
        11.16.2 Krka Group Overview
        11.16.3 Krka Group Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 Krka Group Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Krka Group Recent Developments
    11.17 Nichi-Iko Pharmaceutical
        11.17.1 Nichi-Iko Pharmaceutical Corporation Information
        11.17.2 Nichi-Iko Pharmaceutical Overview
        11.17.3 Nichi-Iko Pharmaceutical Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.17.4 Nichi-Iko Pharmaceutical Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Nichi-Iko Pharmaceutical Recent Developments
    11.18 Valeant
        11.18.1 Valeant Corporation Information
        11.18.2 Valeant Overview
        11.18.3 Valeant Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.18.4 Valeant Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.18.5 Valeant Recent Developments
    11.19 Zydus Cadila
        11.19.1 Zydus Cadila Corporation Information
        11.19.2 Zydus Cadila Overview
        11.19.3 Zydus Cadila Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.19.4 Zydus Cadila Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.19.5 Zydus Cadila Recent Developments
    11.20 Hikma
        11.20.1 Hikma Corporation Information
        11.20.2 Hikma Overview
        11.20.3 Hikma Super Generic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.20.4 Hikma Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.20.5 Hikma Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Super Generic Drugs Industry Chain Analysis
    12.2 Super Generic Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Super Generic Drugs Production Mode & Process
    12.4 Super Generic Drugs Sales and Marketing
        12.4.1 Super Generic Drugs Sales Channels
        12.4.2 Super Generic Drugs Distributors
    12.5 Super Generic Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Super Generic Drugs Industry Trends
    13.2 Super Generic Drugs Market Drivers
    13.3 Super Generic Drugs Market Challenges
    13.4 Super Generic Drugs Market Restraints
14 Key Findings in The Global Super Generic Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Super Generic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Traditional Generic Drugs
    Table 3. Major Manufacturers of Biosimilars
    Table 4. Global Super Generic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Super Generic Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Super Generic Drugs Sales by Region (2017-2022) & (K Units)
    Table 7. Global Super Generic Drugs Sales Market Share by Region (2017-2022)
    Table 8. Global Super Generic Drugs Sales by Region (2023-2028) & (K Units)
    Table 9. Global Super Generic Drugs Sales Market Share by Region (2023-2028)
    Table 10. Global Super Generic Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Super Generic Drugs Revenue Market Share by Region (2017-2022)
    Table 12. Global Super Generic Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Super Generic Drugs Revenue Market Share by Region (2023-2028)
    Table 14. Global Super Generic Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Super Generic Drugs Sales Share by Manufacturers (2017-2022)
    Table 16. Global Super Generic Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Super Generic Drugs Revenue Share by Manufacturers (2017-2022)
    Table 18. Super Generic Drugs Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global Super Generic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Super Generic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Super Generic Drugs as of 2021)
    Table 21. Super Generic Drugs Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Super Generic Drugs Product Offered
    Table 23. Date of Manufacturers Enter into Super Generic Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Super Generic Drugs Sales by Type (2017-2022) & (K Units)
    Table 26. Global Super Generic Drugs Sales by Type (2023-2028) & (K Units)
    Table 27. Global Super Generic Drugs Sales Share by Type (2017-2022)
    Table 28. Global Super Generic Drugs Sales Share by Type (2023-2028)
    Table 29. Global Super Generic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Super Generic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Super Generic Drugs Revenue Share by Type (2017-2022)
    Table 32. Global Super Generic Drugs Revenue Share by Type (2023-2028)
    Table 33. Super Generic Drugs Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global Super Generic Drugs Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global Super Generic Drugs Sales by Application (2017-2022) & (K Units)
    Table 36. Global Super Generic Drugs Sales by Application (2023-2028) & (K Units)
    Table 37. Global Super Generic Drugs Sales Share by Application (2017-2022)
    Table 38. Global Super Generic Drugs Sales Share by Application (2023-2028)
    Table 39. Global Super Generic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Super Generic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Super Generic Drugs Revenue Share by Application (2017-2022)
    Table 42. Global Super Generic Drugs Revenue Share by Application (2023-2028)
    Table 43. Super Generic Drugs Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global Super Generic Drugs Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America Super Generic Drugs Sales by Type (2017-2022) & (K Units)
    Table 46. North America Super Generic Drugs Sales by Type (2023-2028) & (K Units)
    Table 47. North America Super Generic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Super Generic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Super Generic Drugs Sales by Application (2017-2022) & (K Units)
    Table 50. North America Super Generic Drugs Sales by Application (2023-2028) & (K Units)
    Table 51. North America Super Generic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Super Generic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Super Generic Drugs Sales by Country (2017-2022) & (K Units)
    Table 54. North America Super Generic Drugs Sales by Country (2023-2028) & (K Units)
    Table 55. North America Super Generic Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Super Generic Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Super Generic Drugs Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Super Generic Drugs Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Super Generic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Super Generic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Super Generic Drugs Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Super Generic Drugs Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Super Generic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Super Generic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Super Generic Drugs Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Super Generic Drugs Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Super Generic Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Super Generic Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Super Generic Drugs Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Super Generic Drugs Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Super Generic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Super Generic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Super Generic Drugs Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Super Generic Drugs Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Super Generic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Super Generic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Super Generic Drugs Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Super Generic Drugs Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Super Generic Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Super Generic Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Super Generic Drugs Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Super Generic Drugs Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Super Generic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Super Generic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Super Generic Drugs Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Super Generic Drugs Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Super Generic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Super Generic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Super Generic Drugs Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Super Generic Drugs Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Super Generic Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Super Generic Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Super Generic Drugs Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Super Generic Drugs Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Super Generic Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Super Generic Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Super Generic Drugs Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Super Generic Drugs Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Super Generic Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Super Generic Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Super Generic Drugs Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Super Generic Drugs Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Super Generic Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Super Generic Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Teva Corporation Information
    Table 106. Teva Description and Major Businesses
    Table 107. Teva Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. Teva Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Teva Recent Developments
    Table 110. Novartis - Sandoz Corporation Information
    Table 111. Novartis - Sandoz Description and Major Businesses
    Table 112. Novartis - Sandoz Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. Novartis - Sandoz Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Novartis - Sandoz Recent Developments
    Table 115. Mylan Corporation Information
    Table 116. Mylan Description and Major Businesses
    Table 117. Mylan Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. Mylan Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Mylan Recent Developments
    Table 120. Sun Pharmaceutical Corporation Information
    Table 121. Sun Pharmaceutical Description and Major Businesses
    Table 122. Sun Pharmaceutical Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. Sun Pharmaceutical Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Sun Pharmaceutical Recent Developments
    Table 125. Aspen Corporation Information
    Table 126. Aspen Description and Major Businesses
    Table 127. Aspen Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. Aspen Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Aspen Recent Developments
    Table 130. Fresenius Kabi Corporation Information
    Table 131. Fresenius Kabi Description and Major Businesses
    Table 132. Fresenius Kabi Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 133. Fresenius Kabi Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Fresenius Kabi Recent Developments
    Table 135. Pfizer (Hospira) Corporation Information
    Table 136. Pfizer (Hospira) Description and Major Businesses
    Table 137. Pfizer (Hospira) Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 138. Pfizer (Hospira) Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Pfizer (Hospira) Recent Developments
    Table 140. Sanofi Corporation Information
    Table 141. Sanofi Description and Major Businesses
    Table 142. Sanofi Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 143. Sanofi Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Sanofi Recent Developments
    Table 145. Aurobindo Corporation Information
    Table 146. Aurobindo Description and Major Businesses
    Table 147. Aurobindo Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 148. Aurobindo Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Aurobindo Recent Developments
    Table 150. Lupin Corporation Information
    Table 151. Lupin Description and Major Businesses
    Table 152. Lupin Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 153. Lupin Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Lupin Recent Developments
    Table 155. Dr. Reddy's Corporation Information
    Table 156. Dr. Reddy's Description and Major Businesses
    Table 157. Dr. Reddy's Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 158. Dr. Reddy's Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Dr. Reddy's Recent Developments
    Table 160. Apotex Corporation Information
    Table 161. Apotex Description and Major Businesses
    Table 162. Apotex Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 163. Apotex Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Apotex Recent Developments
    Table 165. Cipla Corporation Information
    Table 166. Cipla Description and Major Businesses
    Table 167. Cipla Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 168. Cipla Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Cipla Recent Developments
    Table 170. ENDO (Par Pharmaceutical) Corporation Information
    Table 171. ENDO (Par Pharmaceutical) Description and Major Businesses
    Table 172. ENDO (Par Pharmaceutical) Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 173. ENDO (Par Pharmaceutical) Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. ENDO (Par Pharmaceutical) Recent Developments
    Table 175. Stada Arzneimittel Corporation Information
    Table 176. Stada Arzneimittel Description and Major Businesses
    Table 177. Stada Arzneimittel Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 178. Stada Arzneimittel Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 179. Stada Arzneimittel Recent Developments
    Table 180. Krka Group Corporation Information
    Table 181. Krka Group Description and Major Businesses
    Table 182. Krka Group Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 183. Krka Group Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 184. Krka Group Recent Developments
    Table 185. Nichi-Iko Pharmaceutical Corporation Information
    Table 186. Nichi-Iko Pharmaceutical Description and Major Businesses
    Table 187. Nichi-Iko Pharmaceutical Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 188. Nichi-Iko Pharmaceutical Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 189. Nichi-Iko Pharmaceutical Recent Developments
    Table 190. Valeant Corporation Information
    Table 191. Valeant Description and Major Businesses
    Table 192. Valeant Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 193. Valeant Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 194. Valeant Recent Developments
    Table 195. Zydus Cadila Corporation Information
    Table 196. Zydus Cadila Description and Major Businesses
    Table 197. Zydus Cadila Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 198. Zydus Cadila Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 199. Zydus Cadila Recent Developments
    Table 200. Hikma Corporation Information
    Table 201. Hikma Description and Major Businesses
    Table 202. Hikma Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 203. Hikma Super Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 204. Hikma Recent Developments
    Table 205. Key Raw Materials Lists
    Table 206. Raw Materials Key Suppliers Lists
    Table 207. Super Generic Drugs Distributors List
    Table 208. Super Generic Drugs Customers List
    Table 209. Super Generic Drugs Market Trends
    Table 210. Super Generic Drugs Market Drivers
    Table 211. Super Generic Drugs Market Challenges
    Table 212. Super Generic Drugs Market Restraints
    Table 213. Research Programs/Design for This Report
    Table 214. Key Data Information from Secondary Sources
    Table 215. Key Data Information from Primary Sources
List of Figures
    Figure 1. Super Generic Drugs Product Picture
    Figure 3. Global Super Generic Drugs Market Share by Type in 2021 & 2028
    Figure 3. Traditional Generic Drugs Product Picture
    Figure 4. Biosimilars Product Picture
    Figure 5. Global Super Generic Drugs Market Share by Application in 2021 & 2028
    Figure 6. CNS
    Figure 7. Cardiovascular
    Figure 8. Genitourinary/Hormonal Drugs
    Figure 9. Respiratory
    Figure 10. Rheumatology
    Figure 11. Diabetes
    Figure 12. Oncology
    Figure 13. Others
    Figure 14. Super Generic Drugs Report Years Considered
    Figure 15. Global Super Generic Drugs Sales 2017-2028 (K Units)
    Figure 16. Global Super Generic Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Super Generic Drugs Revenue 2017-2028 (US$ Million)
    Figure 18. Global Super Generic Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 19. Global Super Generic Drugs Sales Market Share by Region (2017-2022)
    Figure 20. Global Super Generic Drugs Sales Market Share by Region (2023-2028)
    Figure 21. North America Super Generic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 22. North America Super Generic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Super Generic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 24. Europe Super Generic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Asia-Pacific Super Generic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 26. Asia-Pacific Super Generic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Latin America Super Generic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 28. Latin America Super Generic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Middle East & Africa Super Generic Drugs Sales YoY (2017-2028) & (K Units)
    Figure 30. Middle East & Africa Super Generic Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. The Super Generic Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 32. The Top 5 and 10 Largest Manufacturers of Super Generic Drugs in the World: Market Share by Super Generic Drugs Revenue in 2021
    Figure 33. Global Super Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 34. Global Super Generic Drugs Sales Market Share by Type (2017-2028)
    Figure 35. Global Super Generic Drugs Revenue Market Share by Type (2017-2028)
    Figure 36. Global Super Generic Drugs Sales Market Share by Application (2017-2028)
    Figure 37. Global Super Generic Drugs Revenue Market Share by Application (2017-2028)
    Figure 38. North America Super Generic Drugs Sales Market Share by Type (2017-2028)
    Figure 39. North America Super Generic Drugs Revenue Market Share by Type (2017-2028)
    Figure 40. North America Super Generic Drugs Sales Market Share by Application (2017-2028)
    Figure 41. North America Super Generic Drugs Revenue Market Share by Application (2017-2028)
    Figure 42. North America Super Generic Drugs Sales Share by Country (2017-2028)
    Figure 43. North America Super Generic Drugs Revenue Share by Country (2017-2028)
    Figure 44. United States Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 45. Canada Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 46. Europe Super Generic Drugs Sales Market Share by Type (2017-2028)
    Figure 47. Europe Super Generic Drugs Revenue Market Share by Type (2017-2028)
    Figure 48. Europe Super Generic Drugs Sales Market Share by Application (2017-2028)
    Figure 49. Europe Super Generic Drugs Revenue Market Share by Application (2017-2028)
    Figure 50. Europe Super Generic Drugs Sales Share by Country (2017-2028)
    Figure 51. Europe Super Generic Drugs Revenue Share by Country (2017-2028)
    Figure 52. Germany Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. France Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. U.K. Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 55. Italy Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 56. Russia Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Super Generic Drugs Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Super Generic Drugs Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Super Generic Drugs Sales Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Super Generic Drugs Revenue Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Super Generic Drugs Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Super Generic Drugs Revenue Share by Region (2017-2028)
    Figure 63. China Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. India Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. China Taiwan Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Super Generic Drugs Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Super Generic Drugs Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Super Generic Drugs Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Super Generic Drugs Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Super Generic Drugs Sales Share by Country (2017-2028)
    Figure 77. Latin America Super Generic Drugs Revenue Share by Country (2017-2028)
    Figure 78. Mexico Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Super Generic Drugs Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Super Generic Drugs Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Super Generic Drugs Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Super Generic Drugs Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Super Generic Drugs Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Super Generic Drugs Revenue Share by Country (2017-2028)
    Figure 87. Turkey Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 89. UAE Super Generic Drugs Revenue (2017-2028) & (US$ Million)
    Figure 90. Super Generic Drugs Value Chain
    Figure 91. Super Generic Drugs Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed